Delcath Systems Inc
Delcath Systems Inc (DCTH) Option Chain
As of September 30, 2026, Delcath Systems Inc is trading at $15.97, a +0.76% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 105.1%. IV Rank is 62%.
Read more
Tracking the DCTH option chain helps you see every strike and expiry on Delcath Systems Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Delcath Systems Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DCTH options activity at a glance. Use our scanner to monitor the DCTH option chain in real time and filter for the DCTH options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DCTH stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the DCTH option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where DCTH stock options are being actively traded and where they are not.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe.
Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Delcath Systems Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen DCTH options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of DCTH stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile75.40% Elevated
- Market cap (M$)554
- 52 weeks high-8.32%
- 52 weeks low96.67%
- Analyst recommendationStrong Buy
1.00 - Target price$24.50
53.41% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-03
- P/E2,618.03
- Future P/E—
- EPS (ttm)0.01
- EPS growth next 5 years37.00%
As of September 30, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.09 | 0 | 0 | -0.17 | 5.97 | 4.70 | 6.90 | 10.00 | -36.75 | — | 1.15 | 0.00 | 1.15 | 0 | 0 | 99.91 |
| 5.80 | 0 | 0 | -0.05 | 3.47 | 2.15 | 4.70 | 12.50 | -20.94 | — | 1.15 | 0.00 | 1.15 | 0 | 0 | 94.20 |
| 37.96 | 257 | 0 | 0.35 | 0.97 | 0.80 | 1.85 | 15.00 | -5.12 | — | 1.15 | 0.00 | 1.15 | 0 | 6 | 62.04 |
| 77.73 | 60 | 0 | 0.85 | 0.00 | — | 0.85 | 17.50 | +10.69 | 1.30 | 2.65 | 1.53 | 0.45 | 2 | 2 | 22.27 |
| 95.45 | 0 | 0 | 0.95 | 0.00 | — | 0.95 | 20.00 | +26.50 | 3.30 | 5.30 | 4.03 | 0.27 | 0 | 0 | 4.55 |
As of September 30, 2026
Scan the full option chain in one place
Browse the full DCTH option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→